Abstract
The tissue microarray technique (TMA) represents a powerful diagnostic "high-throughput" tool to analyse DNA/RNA or protein alterations in large patient cohorts in a time and cost effective way. This review focuses on the clinical application of TMA in renal cell carcinoma in modern "translational" medicine - "from bench to bedside". In particular, the advantages of TMA for diagnosis, prognosis and decisions for therapy will be considered in relation to renal cell cancer.
| Translated title of the contribution | Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma |
|---|---|
| Original language | German |
| Journal | Urologe - Ausgabe A |
| Volume | 45 |
| Issue number | 3 |
| Pages (from-to) | 323-327 |
| Number of pages | 5 |
| ISSN | 0340-2592 |
| DOIs | |
| Publication status | Published - 03.2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)
Fingerprint
Dive into the research topics of 'Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver